…r mortality rates in patients following intracerebral hemorrhage (ICH) (Garrett et al. Neurocrit Care 2010; 12: 199-203; Hays & Diringer. Neurology 2006; 66: 1330-1334; Chung et al. J Korean Neurosurg Soc 2009; 45: 355-359. Free full text at www.jkns.or.kr/htm/fulltext.asp?no=0042009075). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…REPORT FROM THE AAN, APRIL 10-17, 2010 – A new U.S. study reports that glatiramer acetate administered twice per week is as effective as daily dosing (Caon et al. AAN, S11.002). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
REPORT FROM THE AAN, APRIL 10-17, 2010 – Over 4,000 MS patients signed on to the National MS Society press conference and webinar on chronic cerebrospinal venous insufficiency (CCSVI), held April 14th, 2010, during the AAN annual meeting (See Special Report: CCSVI, NeuroSens, February 17, 2010). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Conti…
…A double-blind, placebo-controlled study in Austria reports that nutritional supplementation with omega-3 polyunsaturated fatty acid (PUFA) reduces progression to first-episode psychotic disorder in high-risk individuals (Amminger et al. Arch Gen Psychiatry 2010; 67: 146-154). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
The Canadian EMBOLDEN I trial was a large randomized, double-blind trial comparing quetiapine (300 or 600 mg/day), lithium (600-1800 mg/day) or placebo in 802 patients with bipolar I or II disorder (Young et al. J Clin Psychiatry 2010; 71:150-162). The primary endpoint was the change from baseline to week 8 in Montgomery-Asberg Depression Rating Scale (MADRS) total score. Subscribe to read more It takes 30 seconds or login using your email addres…